透灸治疗无先兆偏头痛的随机对照试验
该随机对照试验纳入60例无先兆偏头痛患者,分为透灸组与温和灸组各30例,每周治疗3次、连续4周。结果显示透灸组总有效率93.33%高于温和灸组80.00%(P<0.05),且VAS评分、头痛强度及MSQ部分维度改善更优。
要点
- 透灸治疗无先兆偏头痛的总有效率优于温和灸。
- 透灸在缓解疼痛和改善生活质量方面均优于温和灸。
- 透灸后患者出现明显的潮红和出汗,且耐受性良好。
核心结论
- 透灸可显著缓解无先兆偏头痛患者的疼痛并改善生活质量。
- 透灸后患者潮红、出汗明显,疗效优于温和灸。
研究设计与样本
- 随机对照试验,纳入60例无先兆偏头痛患者,随机分为透灸组和温和灸组各30例。
- 两组均每周治疗3次、连续4周,随访至治疗后4周和16周。
主要发现
- 透灸组总有效率为93.33%,显著高于温和灸组的80.00%(P<0.05)。
- 透灸组VAS评分、头痛强度及MSQ角色限制和角色预防评分的改善均优于温和灸组(P<0.05)。
- 透灸组出现瘙痒、麻木、寒冷等灸感及灸后潮红、出汗的人次均显著多于温和灸组(P<0.01)。
- 两组安全性评价差异无统计学意义(P>0.05)。
关键数值与推荐
- 总有效率:透灸组93.33% vs 温和灸组80.00%,P<0.05。
- VAS评分、头痛强度、MSQ角色限制和角色预防评分改善透灸组优于温和灸组,P<0.05。
- 瘙痒、麻木、寒冷灸感及潮红、出汗人次透灸组均显著多于温和灸组,P<0.01。
临床怎么用
- 对无先兆偏头痛患者可考虑采用透灸治疗,每周3次、连续4周。
- 治疗中可观察灸感及灸后潮红出汗反应,作为透灸操作的特征性表现。
局限性
- 样本量较小,共60例,来自单一医院针灸门诊。
- 随访时间较短,仅至治疗后16周。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To observe the clinical effect of penetrating moxibustion on migraine without aura (MO) patients. METHODS: Totally 60 MO patients from the Acupuncture Clinic of the Third Affiliated Hospital of Henan University of Chinese Medicine were collected from November 2015 to February 2017. All patients were assigned to a treatment group and a control group using a random number table, 30 cases in each group. The treatment group was treated with penetrating moxibustion, and the control group was treated with mild moxibustion, thrice a week for 4 consecutive weeks. The total effective rate, Visual Analogue Scale (VAS) scores, headache intensity, and Migraine Specific Quality of Life Questionnaire (MSQ) scores of patients after treatment were compared between the two groups. The moxibustion sensation and reaction after moxibustion were observed, and the adverse reactions were evaluated. All patients were followed up at 4 and 16 weeks after treatment. RESULTS: The total effective rate of the treatment group was significantly higher than that of the control group (93.33% vs. 80.00%, P<0.05). The improvement of VAS scores, headache intensity, and the role restrictive and role preventive scores in MSQ in the treatment group was better than those in the control group (P<0.05). The person-time of moxibustion sensations of itching, numbness and cold as well as flushing and sweating after moxibustion in the treatment group was all significantly higher than that in the control group (P<0.01). There was no significant difference in safety evaluation between the two groups (P>0.05). CONCLUSIONS: Penetrating moxibustion can significantly relieve pain and improve quality of life of MO patients. After penetrating moxibustion, flushing and sweating of patients were obvious, and the curative effect was superior to the mild moxibustion.
引用
- Gao L, Xie J, Li X, et al. Effect and Safety of Penetrating Moxibustion in Treatment of Migraine without Aura: A Randomized Controlled Trial. Chin J Integr Med. 2021. PMID: 33881716. doi:10.1007/s11655-021-3327-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。